CCO Virtual and Regional HIV Symposia: Advances in HIV Treatment, Prevention, and Cure

It is a dynamic time in HIV prevention, with a new long-acting option and several other exciting approaches under clinical investigation. Here, I summarize key updates in the current HIV prevention landscape that have occurred over the past year.

Colleen Kelley, MD, MPH Released: November 29, 2022

The HIV treatment landscape saw continued progress through 2022 with exciting new data on existing and emerging strategies across various stages of HIV therapy, from initial ART to switch strategies for people with viral suppression, as well as options for people who have extensive treatment experience and multiclass drug resistance.

Monica Gandhi, MD, MPH Released: December 2, 2022

Learn about important clinical advances in HIV treatment that have taken place over the past year, including key updates in first-line therapy, new switch strategies for patients with viral suppression on their current ART, and the latest insights on selecting new regimens for patients experiencing virologic failure.

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI Released: October 4, 2022

Learn about important clinical advances in HIV biomedical prevention that have taken place over the past year, including updates in pre-exposure prophylaxis eligibility considerations and regimen selection, the emergence of a new long-acting injectable option, the latest insights on population-specific strategies, expert perspectives on improving equity in access, and broadening prevention strategies for other STIs.

Gregory Huhn, MD, MPHTM Colleen Kelley, MD, MPH Darrell H. S. Tan, MD, FRCPC, PhD Released: October 4, 2022

Learn about key concepts and mechanisms, recent clinical studies, important ethical considerations, and current directions in HIV cure research from this expert-authored downloadable slideset.

Katharine J. Bar, MD David M. Margolis, MD Released: October 4, 2022

Watch and listen as a global panel of expert faculty provides insights on key clinical advances in HIV treatment that have taken place over the past year, including updates in first-line therapy, new switch strategies for patients with viral suppression on their current ART, and new regimens for patients experiencing virologic failure.

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI Released: November 17, 2022

State-of-the-Art Overview of Key Updates in Initial HIV Treatment

Faculty Discussion: Key Updates in Initial HIV Treatment

Advances in Switch Strategies for Patients With Viral Suppression on Current ART: Long-Acting ART

Advances in Switch Strategies for Patients With Viral Suppression on Current ART: M184V/I or Weight Gain

New and Emerging Strategies for Patients With Virologic Failure

Questions and Answers

Watch and listen as a global panel of expert faculty provides insights on important clinical advances in HIV prevention that have taken place during the past year, including updates in pre-exposure prophylaxis eligibility considerations and regimen selection, the emergence of a new long-acting injectable option, the latest insights on population-specific strategies, expert perspectives on improving equity in access, and broadening prevention strategies for other STIs.

Gregory Huhn, MD, MPHTM Colleen Kelley, MD, MPH Darrell H. S. Tan, MD, FRCPC, PhD Released: November 4, 2022

State-of-the-Art Overview of PrEP Eligibility and Regimen Selection

Current Insights on Population-Specific PrEP Options

Moving Toward Greater Equity in HIV Prevention Services and Broadening the Prevention Arsenal

Questions and Answers

Watch and listen as expert faculty provide insights on key concepts and mechanisms, recent clinical studies, important ethical considerations, and current directions in HIV cure research.

Katharine J. Bar, MD David M. Margolis, MD Released: November 10, 2022

HIV Cure Research: Concepts and Mechanisms

HIV Cure Research: Clinical Studies

HIV Cure Research: Faculty Discussion

HIV Cure Research: Ethical Considerations

Questions and Answers